The field of microbial enzyme research is rapidly evolving as biotechnology and industrial processes increasingly depend on the exploitation of microbial ...

SAN DIEGO, CA - January 27, 2026 (NEWMEDIAWIRE) - Quantumzyme Corp. (OTC: QTZM), a biotransformation company focused on sustainable pharmaceutical manufacturing, today announced a breakthrough ...

Scientists at the Sloan Kettering Institute have combined biochemical and computational methods to visualize how an important cancer-related protein changes shape during a chemical reaction. The ...

SAN DIEGO, CA - November 19, 2025 (NEWMEDIAWIRE) - Quantumzyme Corp. (OTCQB: QTZM), a global leader in computational enzyme engineering, today announced its participation in the Catalysis and Chemical ...

SAN DIEGO, CA - January 30, 2026 (NEWMEDIAWIRE) - Quantumzyme Corp. (OTC: QTZM), a biotransformation company focused on sustainable pharmaceutical manufacturing, today announced that its research has ...

Researchers at the University created an artificial intelligence model named EZSpecificity to test how well certain enzymes and substrates bind to each other. Huimin Zhao and Diwakar Shukla, ...

Aptamers are single-stranded oligonucleotides generated by the systematic evolution of ligands by exponential enrichment (SELEX). They have a wide variety of applications, but computational approaches ...

During 2025, Quantumzyme continued to advance its operations as an early-stage biotechnology company focused on enzyme research and development for potential applications in sustainable chemistry. Key ...

As researchers look for ways to develop and improve everyday products ranging from fuel to medicines, enzymes provide nature's example of the control needed to make chemical reactions work in desired ...

SAN DIEGO, CA - January 27, 2026 (NEWMEDIAWIRE) - Quantumzyme Corp. (OTC: QTZM), a biotransformation company focused on sustainable pharmaceutical manufacturing, today announced a breakthrough ...